other material
confidence high
sentiment positive
materiality 0.40
Lakewood-Amedex redeems all 127,097 Series C preferred shares for $1.27M cash
Lakewood-Amedex Biotherapeutics Inc.
- Redeemed 127,097 Series C Convertible Preferred shares at $10.00 face value, aggregate $1,270,970 paid in cash from cash on hand.
- Redemption agreement dated Nov 2, 2026 with Shakawe Capital LLC, holder of all Series C preferred; closing occurred Nov 4, 2026.
- Following redemption, no preferred stock and no outstanding indebtedness for borrowed money remain; redeemed shares returned to treasury.
- Company says the move eliminates potential dilution from Series C conversion and removes financing restrictions tied to the instrument.
- CEO Kelvin Cooper said the redemption simplifies the capital structure and gives greater financial flexibility for development programs.